Ustekinumab for the treatment of psoriatic arthritis

被引：1
|
作者：
Chandler, David John [1 ]
Bewley, Anthony [2 ]
机构：
[1] Univ Oxford, Weatherall Inst Mol Med, Oxford OX3 9DS, England
[2] Royal London Hosp, London E1 1BB, England
来源：
EXPERT REVIEW OF CLINICAL PHARMACOLOGY | 2014年 / 7卷 / 02期
关键词：
biologics; cutaneous immunology; IL-12; IL-23; psoriasis; psoriatic arthritis; ustekinumab; TO-SEVERE PSORIASIS; MONOCLONAL-ANTIBODY; DOUBLE-BLIND; RHEUMATOID-ARTHRITIS; CARDIOVASCULAR EVENTS; INCREASED EXPRESSION; FIBROBLAST FUNCTION; PLAQUE PSORIASIS; TNF INHIBITION; GROWTH-FACTOR;
D O I：
10.1586/17512433.2014.888310
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
Psoriatic arthritis occurs commonly in those with psoriasis and is associated with progressive joint destruction, physical disability, reduced quality of life and increased mortality. For many patients the currently available treatment options including the anti-TNF treatments are inadequate. Recent data suggest that ustekinumab can provide an effective treatment option in these patients. We discuss the role of ustekinumab in the treatment of psoriatic arthritis and highlight areas requiring further work.
引用
收藏
页码：111 / 121
页数：11
相关论文
共 50 条
  • [41] COMPARATIVE EFFECTIVENESS OF ADALIMUMAB AND USTEKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS
    Wilson, J.
    Le Reun, C.
    Robbins, A.
    Joshi, A.
    [J]. INTERNAL MEDICINE JOURNAL, 2014, 44 : 36 - 36
  • [42] POPULATION PHARMACOKINETICS OF USTEKINUMAB IN PATIENTS WITH ACTIVE PSORIATIC ARTHRITIS
    Zhu, Yaowei
    Mendelsohn, Alan
    Pendley, Charles
    Davis, Hugh M.
    Zhou, Honghui
    [J]. JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 50 (09): : 1073 - 1073
  • [43] Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice
    Almirall, Miriam
    Rodriguez, Jesus
    Mateo, Lourdes
    Manuel Carrascosa, Jose
    Notario, Jaime
    Gallardo, Fernando
    [J]. CLINICAL RHEUMATOLOGY, 2017, 36 (02) : 439 - 443
  • [44] Treatment with ustekinumab in a Spanish cohort of patients with psoriasis and psoriatic arthritis in daily clinical practice
    Miriam Almirall
    Jesús Rodriguez
    Lourdes Mateo
    José Manuel Carrascosa
    Jaime Notario
    Fernando Gallardo
    [J]. Clinical Rheumatology, 2017, 36 : 439 - 443
  • [45] COST EFFECTIVENESS ANALYSIS OF SECUKINUMAB VERSUS USTEKINUMAB FOR THE TREATMENT OF PSORIATIC ARTHRITIS IN THE UNITED STATES
    Bilal, J.
    Urbine, T.
    Saligrama, P. T.
    Khalil, M. J.
    Malone, D. C.
    Bhattacharjee, S.
    [J]. VALUE IN HEALTH, 2018, 21 : S294 - S294
  • [46] TREATMENT EFFECT OF USTEKINUMAB ON FATIGUE IN PATIENTS WITH PSORIATIC ARTHRITIS: RESULTS FROM PSUMMIT 2
    Ritchlin, C.
    Rahman, P.
    Puig, L.
    Gottlieb, A. B.
    Kavanaugh, A.
    McInnes, I. B.
    Li, S.
    Wang, Y.
    Ganguly, R.
    Mendelsohn, A. M.
    Han, C.
    [J]. CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2014, 32 (05) : 824 - 824
  • [47] SAFETY AND PERSISTENCE OF USTEKINUMAB IN PATIENTS WITH PSORIATIC ARTHRITIS IN BIOBADASER
    Busquets-Perez, N.
    Sanchez-Piedra, C.
    Vela-Casasempere, P.
    Freire-Gonzalez, M.
    Bohorquez, C.
    Exposito, L.
    Magallon, B.
    Manero, F.
    Montes, J. Del Pino
    Torne, C. Diaz
    Martin Domenech, R.
    Pascual, M.
    Sanchez-Alonso, F.
    [J]. ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1668 - 1668
  • [48] Ustekinumab-induced Sarcoidosis in a Patient with Psoriatic Arthritis
    Kobak, Senol
    Semiz, Huseyin
    [J]. CURRENT DRUG SAFETY, 2020, 15 (02) : 163 - 166
  • [49] Certolizumab Pegol (Cimzia) and Ustekinumab (Stelara) for Psoriatic Arthritis
    不详
    [J]. MEDICAL LETTER ON DRUGS AND THERAPEUTICS, 2014, 56 (1435): : 10 - 12
  • [50] Onset of psoriatic arthritis during ustekinumab treatment for psoriasis: a case series of seven patients
    Jones, B. B.
    Millsop, J. W.
    Walsh, J. A.
    Krueger, G. G.
    Duffin, K. Callis
    [J]. BRITISH JOURNAL OF DERMATOLOGY, 2015, 173 (01) : 272 - 274
12345